# Effect of Papillary Epinephrine Spraying on Post-ERCP Pancreatitis in Patients Received Rectal Indomethacin

> **NCT03057769** · NA · TERMINATED · sponsor: **Air Force Military Medical University, China** · enrollment: 3300 (actual)

## Conditions studied

- Pancreatitis
- Endoscopic Retrograde Cholangiopancreatography

## Interventions

- **DRUG:** Papillary epinephrine spraying
- **DRUG:** Papillary saline spraying
- **DRUG:** Indomethacin

## Key facts

- **NCT ID:** NCT03057769
- **Lead sponsor:** Air Force Military Medical University, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-01
- **Primary completion:** 2017-10-26
- **Final completion:** 2017-10-26
- **Target enrollment:** 3300 (ACTUAL)
- **Why stopped:** This study was terminated because of an interim analysis suggesting futility of papillary epinephrine spraying in PEP prevention.
- **Last updated:** 2017-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03057769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03057769, "Effect of Papillary Epinephrine Spraying on Post-ERCP Pancreatitis in Patients Received Rectal Indomethacin". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03057769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*